Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

beta Amyloid anticorps (AA 1-17)

Abeta Reactivité: Humain WB, ELISA Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN1842481
  • Antigène Voir toutes beta Amyloid (Abeta) Anticorps
    beta Amyloid (Abeta) (Amyloid beta (Abeta))
    Épitope
    • 18
    • 18
    • 13
    • 6
    • 6
    • 4
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1-17
    Reactivité
    • 71
    • 22
    • 15
    • 4
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 42
    • 27
    • 3
    • 2
    Lapin
    Clonalité
    • 38
    • 30
    • 1
    Polyclonal
    Conjugué
    • 64
    • 5
    • 2
    • 1
    • 1
    • 1
    Cet anticorp beta Amyloid est non-conjugé
    Application
    • 53
    • 49
    • 30
    • 17
    • 15
    • 13
    • 9
    • 5
    • 5
    • 4
    • 4
    • 4
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    Western Blotting (WB), ELISA
    Specificité
    This antibody is specific to human beta-amyloid 1-40 and beta-amyloid 1-42 peptides.
    Purification
    Immunoaffinity chromatography
    Immunogène
    A synthetic peptide corresponding to AA 1-17 of beta-amyloid conjugated to KLH
    Isotype
    IgG
    Top Product
    Discover our top product Abeta Anticorps primaire
  • Indications d'application
    Working concentrations for specific applications should be determined by the investigator. Appropriate concentrations will be affected by several factors,
    Including secondary antibody affinity, antigen concentration, sensitivity of detection method, temperature, and length of incubations, etc. The suitability of this antibody for applications other than those listed below has not been determined. The following concentration ranges are recommended starting points for this product.

    ELISA: 0. 1-1 µg/mL
    Western blot: 0. 1-1. 0 µg/mL
    Immunofluorescence: 5-20 µg/mL
    Other applications: user-optimized
    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Reconstitution
    Reconstitute the lyophilized antibody with deionized water (or equivalent) to a final antibody concentration of 0.5 mg/mL.
    Concentration
    0.5 mg/mL
    Buffer
    lyophilized with PBS, pH 7.4, containing 0.02 % sodium azide
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    WARNING: Reagents contain sodium azide. Sodium azide is very toxic if ingested or inhaled. Avoid contact with skin, eyes, or clothing. Wear eye or face protection when handling. If skin or eye contact occurs, wash with copious amounts of water. If ingested or inhaled, contact a physician immediately. Sodium azide yields toxic hydrazoic acid under acidic conditions. Dilute azide-containing compounds in running water before discarding to avoid accumulation of potentially explosive deposits in lead or copper plumbing.
    Conseil sur la manipulation
    Avoid repeated freezing and thawing.
    Stock
    -20 °C
    Stockage commentaire
    The antibody is stable in lyophilized form if stored at -20 °C or below. The reconstituted antibody can be stored for 2-3 weeks at 2-8 °C. For long term storage, aliquot and store at -20 °C or below.
  • Antigène
    beta Amyloid (Abeta) (Amyloid beta (Abeta))
    Autre désignation
    beta-Amyloid (Abeta Produits)
    Synonymes
    anticorps AAA, anticorps ABETA, anticorps ABPP, anticorps AD1, anticorps APPI, anticorps CTFgamma, anticorps CVAP, anticorps PN-II, anticorps PN2, anticorps aaa, anticorps abeta, anticorps abpp, anticorps ad1, anticorps appi, anticorps ctfgamma, anticorps cvap, anticorps pn2, anticorps Abeta, anticorps Abpp, anticorps Adap, anticorps Ag, anticorps Cvap, anticorps E030013M08Rik, anticorps betaApp, anticorps amyloid beta precursor protein, anticorps amyloid beta (A4) precursor protein, anticorps APP, anticorps app, anticorps App
    Sujet
    A number of mutations, identified in the gene encoding the beta-amyloid precursor protein (betaAPP), have been linked to early-onset Familial Alzheimers Disease. betaAPP is cleaved sequentially by the proteolytic enzymes beta-secretase and gamma-secretase to produce beta-amyloid (Abeta) peptides with the Abeta1-42(43) and the Abeta1-40 forms being the most prevalent. Secreted Abeta peptides can bind to scavenger receptors and the receptor for advanced glycation endproducts. Abeta peptides are degraded either via a reuptake mechanism followed by endosomal degradation or by an extracellular insulin-degrading enzyme. Extracellular accumulation of Abeta leads to formation of aggregates, fibrils, and eventually amyloid deposits called neuritic plaques, a hallmark of Alzheimer's disease. beta-amyloid antibodies and peptides have been developed as tools for elucidating the biology of Alzheimers disease.
    Pathways
    Inflammasome
Vous êtes ici:
Support technique